Depression in Parkinson's Disease - Part 2: Therapy and Management

被引:3
|
作者
Storch, A.
Schneider, C.
Ebersbach, G.
Fuchs, G.
Jost, W. H.
Odin, P.
Reifschneider, G.
Bauer, M.
机构
[1] Klinik und Poliklinik für Neurologie, Universitätsklinikum Carl Gustav Carus, Dresden
[2] Neurologisches Fachkrankenhaus für Bewegungsstörungen/Parkinson, Beelitz-Heilstätten
[3] Neurologisches Krankenhaus, Parkinson-Fachklinik, Wolfach
[4] Deutsche Klinik für Diagnostik (DKD), Wiesbaden
[5] Neurologische Klinik, Klinikum Bremerhaven Reinkenheide, Bremerhaven
[6] Neuro Centrum Odenwald, Erbach
[7] Klinik für Psychiatrie und Psychotherapie, Universitätsklinikum Carl Gustav Carus, Dresden
关键词
depression; Parkinson's disease; antidepressants; therapy; non-pharmacological treatment; management; TREATMENT-RESISTANT DEPRESSION; TRANSCRANIAL MAGNETIC STIMULATION; DOUBLE-BLIND; CONTROLLED-TRIAL; ELECTROCONVULSIVE-THERAPY; PRAMIPEXOLE; FLUOXETINE; SYMPTOMS; PLACEBO; DOPAMINE;
D O I
10.1055/s-0029-1245535
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
A good number of different methods and antidepressive agents are now available for the management of depressive symptoms, the efficacy of which has been confirmed by clinical studies. Various approaches - be it medication, electroconvulsive therapy (ECT), psychoeducation and psychotherapy - have also been developed to treat depression in patients with Parkinson's disease. Unfortunately, only a few controlled studies exist for this very specific group of patients. Systematic knowledge of treatment options, however, is lacking. Efficient management of depressive symptoms is absolutely indispensable considering the proven impact of a depression on the patients' quality of life. So far, more than half of the patients afflicted with Parkinson's disease and depression do not receive proper antidepressive therapy. This survey gives an overview on the pharmacological, somatic and psychological procedures of treatment applied in this group of patients, along with useful suggestions.
引用
收藏
页码:456 / 467
页数:12
相关论文
共 50 条
  • [1] Management of depression in Parkinson's disease
    Aarsland, D.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2006, 248 (1-2) : 320 - 320
  • [2] Management of anxiety and depression in Parkinson's disease
    Singhal, BS
    Lalkaka, JA
    Sheth, A
    [J]. MAPPING THE PROGRESS OF ALZHEIMER'S AND PARKINSON'S DISEASE, 2002, 51 : 417 - 422
  • [3] Depression in Parkinson's Disease: Identification and Management
    Chen, Jack J.
    Marsh, Laura
    [J]. PHARMACOTHERAPY, 2013, 33 (09): : 972 - 983
  • [4] Depression in Parkinson's disease: diagnosis and management
    Latoo, Javed
    Mistry, Minal
    Dunne, Francis J.
    [J]. BRITISH JOURNAL OF HOSPITAL MEDICINE, 2012, 73 (06) : 331 - 334
  • [5] The pharmacologic management of depression in Parkinson's disease
    Schreiber, Matthew A.
    Thompson, Alexander W.
    [J]. DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE, 2013, 3 : 1 - 9
  • [6] Treating depression in Parkinson's disease with electroconvulsive therapy
    Guertzenstein, E.
    Nobrega, J. C. M.
    Teixeira, M. J.
    [J]. INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2010, 14 : 24 - 25
  • [7] Current approaches to management of depression in Parkinson's Disease
    Vajda, FJE
    Solinas, C
    [J]. JOURNAL OF CLINICAL NEUROSCIENCE, 2005, 12 (07) : 739 - 743
  • [8] Cognitive Behaviour Therapy for Depression and Anxiety in Parkinson's Disease
    Egan, Sarah J.
    Laidlaw, Ken
    Starkstein, Sergio
    [J]. JOURNAL OF PARKINSONS DISEASE, 2015, 5 (03) : 443 - 451
  • [9] A survey of the identification and management of depression in people with Parkinson's disease
    Simpson, A. C.
    Samuel, M.
    Brown, R. G.
    [J]. MOVEMENT DISORDERS, 2012, 27 : S287 - S288
  • [10] Optimising levodopa therapy for the management of Parkinson's disease
    Stocchi, F
    [J]. JOURNAL OF NEUROLOGY, 2005, 252 (Suppl 4) : 43 - 48